1Sen GC.Viruses and interferons[J].Annu Rev Microbiol,2001,55:255～281.
2Biron CA,Nguyen KB,Pien GC,et al.Natural killer cells in antiviral defense:function and regulation by innate cytokines[J].Annu Rev Immunol,1999,17:189～220.
3Siegal FP,Kadowaki N,Shodell M,et al.The nature of the principal type 1 interferon-producing cells in human blood[J].Science,1999,284(5421):1835～1837.
4Diebold SS,Montoya M,Unger H,et al.Viral infection switches nonplasmacytoid dendritic cells into high interferon producers[J].Nature,2003,424 (6946):324～328.
5Barnes BJ,Moore PA,Pitha PM.Virus-specific activation of a novel interferon regulatory factor,IRF-5,results in the induction of distinct interferon alpha genes[J].J Biol Chem,2001,276 (26):23382～23390.
6Coccia EM,Severa M,Giacomini E,et al.Viral infection and Tolllike receptor agonists induce a differential expression of type Ⅰ and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells[J].Eur J Immunol,2004,34 (3):796～805.
7Houle JL,Santoro N.Analysis of human interferon-alpha gene promoters by multiple sequence alignment[ J].J Interferon Cytokine Res,1996,16(2):93～98.
8Juang YT,Lowther W,KellumM,et al.Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3[J].Proc Natl Acad Sci USA,1998,95 (17):9837～9842.
9Marie I,Durbin JE,Levy DE.Differential viral induction of distinc interferon-alpha genes by positive feedback through interferon regulatory factor-7[J].EMBO J,1998,17(22):6660～6669.
10Lin R,Genin P,Mamane Y,et al.Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/ beta interferon genes by interferon regulatory factors 3 and 7[J].Mol Cell Biol,2000,20 (17):6342～6353.
二级参考文献13
1Schirmbeck R, Zheng X, Roggendorf M, et al. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J Immunol, 2001, 166: 1405-1413.
2Psncholi P, Lee DH, Tackney C, et al. DNA prime/canarypos boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee. Hepatology, 2001, 33: 448-454.
3Malanchere-Bres E, Payette PJ, Mancini M, et al. CpG oligodeoxynucleotides with hepatitis B surface antigen for vaccination in HBsAg-transgenic mice. J Virol 2001, 75: 6482-6491.
4Preikschat P, Gunther S, Reinhold S, et al. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology, 2002, 35:466-477.
5You Z, Huang XF, Hester J, et al. Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway. J Immunol, 2000, 165: 4581-4591.
6Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8(+)cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med, 2000, 191: 1269-1280.
7Reignat S, Webster GJ, Brown D, et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med, 2002, 195: 1089-1101.
8Kakimi K, Guidotti LG, Kezuka Y, et al. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med,2000, 192: 921-930.
9Liu ZX, Govindarajan S, Okamoto S, et al. NK cells causes liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol. 2000, 164: 6480-6486.
10Pol S, Nalpas B, Driss F, et al. Efficacy and limitation of a specific immunotherapy in chronic hepatitis B. J Hepatology, 2001, 34:917-921.
